Shire eyes Europe with UCB drug buy

In nabbing rights to UCB's attention deficit Equasym drugs, Shire has built a bridge into Europe, a market the company hasn't yet mined for ADHD riches. Release l Report 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.